SCHEMBL31367989

SCHEMBL31367989

Cc1cc(Br)cc(C)c1-n1nc2nc(N3CCOCC3)[nH]c(=S)c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.39
NLRP3 Q96P20 2/20 0.37
KMT2A Q03164 5/20 0.33
MEN1 O00255 3/20 0.33
TSHR P16473 3/20 0.33
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
CDC7 O00311 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
ROCK1 Q13464 1/20 0.32
DBF4 Q9UBU7 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
EGFR P00533 1/20 0.32
ALDH1A1 P00352 2/20 0.32
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31367993 0.90 PIM1 (0.35) PIM1NLRP3KMT2AMEN1HSD17B10
SCHEMBL31367967 0.87 NLRP3 (0.45) PIM1NLRP3KMT2AMEN1TSHR
SCHEMBL31367977 0.87 NLRP3 (0.45) PIM1NLRP3KMT2AMEN1TSHR
SCHEMBL31367984 0.86 PIM1 (0.32) PIM1KMT2AMEN1TSHRHSD17B10
SCHEMBL31367980 0.76 NLRP3 (0.42) PIM1NLRP3KMT2AMEN1KDM4E
SCHEMBL31368007 0.76 NLRP3 (0.42) PIM1NLRP3KMT2AMEN1KDM4E
SCHEMBL31368006 0.76 NLRP3 (0.42) PIM1NLRP3KMT2AMEN1KDM4E
SCHEMBL31367996 0.76 PDE2A (0.31)
SCHEMBL31367976 0.74 KMT2A (0.41) NLRP3KMT2AMEN1TSHRHSD17B10
SCHEMBL29294062 0.71 NLRP3 (0.69) PIM1NLRP3KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092051-A1 NLRP3 MODULATORS AND USE THEREOF Bioentropy Inc. (US) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250092051-A1 NLRP3 MODULATORS AND USE THEREOF NLRP3, NLRP1, NOD1 PIM1 3046/4885NLRP3 1/4885KMT2A 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.